Drug Delivery

Accelerating Development and Enhancing User Experience

As the world’s healthcare needs change, innovation in drug delivery becomes increasingly vital. With rising chronic conditions and an aging population, optimizing medication delivery and enhancing patient experience are essential. Advancements will be driven by novel formulations, cutting-edge technologies, and expanding markets. To thrive, companies must address several challenges, ensuring devices meet market and user needs, adhering to stringent quality and regulatory standards, and controlling costs.

Accelerate Development

We fast-track the development of drug delivery systems from stakeholder research to clinical manufacturing.

Advancing drug delivery devices from design to clinical manufacture.

Optimize User Experience

We enhance the user experience of drug delivery devices, ensuring they are intuitive and effective.

Ensuring safety and optimal user experience through usability and stakeholder studies.

Specialized in Advanced Delivery Technologies

Our expertise supports established delivery routes such as parenteral (including fixed and variable dose injectors, large volume on-body delivery systems, infusion pumps), respiratory (inhalation, deep lung, nasal), sublingual, and transdermal. Additionally, we extend to novel drug delivery routes, addressing challenges such as ocular delivery, brain delivery, and other direct-to-organ delivery.

Collaborating with Re-Vana Therapeutics on a novel delivery system for the sustained release of active pharmaceutical ingredient (API) ophthalmic formulations.

Learn More

From Opportunity to Clinic & Commercial

Insights & Strategy

Patient, HCP and stakeholder insights to identify the right user needs and design inputs

Due Diligence & Feasibility

Assessment of device readiness, technology, markets, commercial and regulatory status.

Device Design

Device engineering – concepting, prototyping and testing. Digital and connected device development.

Packaging & Sustainability

Development of inclusive device and packaging design leveraging materials science and user centered design.

Verification

Expertise and facilities to confirm devices meet requirements for clinic and commercial launch.

Human Factors Evaluation

Device evaluation – formative, summative study design and facilitation.

Manufacturing

Pilot manufacture for clinical trials, supplier management and process development.

Quality & Regulatory

DHF and technical file creation / remediation, QMS (ISO13485).

Case Studies

Multi-application sensor platform to analyze patient behaviour

Drug delivery devices can be notoriously tricky to use, so our technology enables improved studies that can distinguish use error from drug performance. This allows developers to focus investment correctly, reduce costs and accelerate a new treatment’s journey to market.

Case Studies

Therapy assistant for parenteral drugs

Patients suffering from chronic diseases such as rheumatoid arthritis or multiple sclerosis often follow a complicated treatment regimen at home. They sometimes need to store their drugs in the fridge, warm them up to the correct temperature for injection, prepare their auto-injector for use and finally dispose of the used device safely.

Understanding Clients’ Program Requirements

We have a deep understanding of our clients’ markets and the needs of all stakeholders. Our integrated approach ensures every decision aligns with strategic goals, balancing long-term value with immediate needs to keep clients at the forefront of drug delivery innovation. We offer expert advice to ensure our clients’ strategies effectively meet market demands.

Optimizing Outcomes through Agile Strategies

We remain flexible and responsive to changing requirements by adopting an agile methodology. By employing a risk-based approach, we identify and address potential issues throughout the project.

“It’s that glue that really unites this group of people. I feel like I’m part of that glue now too. It’s such a fantastic feeling to be part of this community. I think it’s that glue that elevates the brilliance, competency, and expertise to a level you wouldn’t find anywhere else.”

Dr Annie Lent

Founder, Lent Innovations

Capabilities

View all

Sustainable & Circular Design

With extensive industry experience and a focus on technological advancements, we offer insights that drive progress towards sustainability goals.

Product Strategy & Innovation

Creating the data, analysis and strategies for evidence based innovation decisions

Human-Centered Design

Creating compelling user experiences for brands, packaging, products and services.

Electronics & Software Engineering

World class digital and data innovation for the consumer, healthcare and industrial sectors, from concept to global launch.

Manufacturing Engineering & Industrialization

Engineering and management creating a seamless transition from prototype to mass production for rapid launch

Design Verification & Test Engineering

Prototyping and lab testing new products. Innovating while meeting regulatory standards. Proving performance at speed.

Mechanical & Industrial Design Engineering

Transforming concepts and new technology into breakthrough manufactured products

Quality & Regulatory Compliance

Meeting the requirements of regulators around the world

Applied Science & Technology Development

Applying scientific rigor to create robust product technologies

Positioned for Innovation

Located at the heart of innovation in Cambridge, UK, and Raleigh, North Carolina, our bases are strategically positioned to tap into the world’s leading research and development communities.

ISO-Certified Management System

To support our product development and prototype manufacturing services, CDP’s Quality Management System is certified to ISO 13485:2016 by Intertek Medical Notified Body and ISO 9001:2015 by Intertek Certification Ltd. We are also certified to ISO 27001:2022 by Intertek Certification Ltd to support the maintenance of the confidentiality, availability and integrity of our clients data.

Client-Centric Intellectual Property Approach

Our clients fully own all intellectual property we help create. We equip them with the tools and knowledge to enable lasting independence.

Advancing Injectable Drug Delivery Systems

Unlock expert opinions and insights with four in-depth interviews on the challenges of parenteral innovation.

Download

|Cambridge Design Partnership | Future of Respiratory Drug Delivery

Breathing New Life: Industry Insights into the future of Respiratory Drug Delivery

Discover the exciting possibilities on the horizon for inhalation device design with our latest resource. This e-book explores recent advancements and highlights innovative strategies crucial for developing significant new treatments.

Download

Meet The Team

Clare Beddoes

Head of Drug Delivery

Steve Augustyn

Deputy Head of Drug Delivery

Matt Fordham

Deputy Head of Drug Delivery

Hans Jensen

Business Development Lead, Drug Delivery

CONTACT THE DRUG DELIVERY TEAM

Featured Insights

Analysis

Drug Delivery

Healthcare

Delivering complexity: device considerations for two-component injectable formulations

8th October 2025

Two-component injectables promise more stable, effective treatments but create new hurdles in reconstitution and delivery. From lyophilised powders to dual-chamber systems, this article explores how device innovation is making complex therapies simpler, safer, and more accessible beyond the clinic.

Designed to deliver: How collaboration created an award-winning device that puts patients first

16th July 2025

Our work with Credence MedSystems won a 2025 Red Dot Design Concept Award – but more importantly, it could change the lives of countless people who need to self-administer two drugs in one injection at home. Read more on the three insights behind project success.

Drug Delivery to the Brain: Engineering Precision Across Novel Modalities

2nd December 2025

Neurodegenerative diseases such as Alzheimer’s disease (AD), Parkinson’s disease (PD), motor neuron disease (MND, including amyotrophic lateral sclerosis, (ALS)), and frontotemporal dementia (FTD) remain areas with limited disease-modifying treatments. Therapeutic pipelines in this area are increasingly dominated by antisense oligonucleotides (ASOs), RNA interference (RNAi) molecules, monoclonal antibodies, and viral gene therapies such as adeno-associated virus […]

VIEW ALL

FAQs

Explore our FAQs to find out more about how our Drug Delivery team can accelerate your drug delivery device design and enhance user experience.

Who are your typical drug delivery clients?

Mainly a split between BioPharma companies bringing drug products to the market using drug delivery devices and Medtech companies developing and manufacturing drug delivery devices

What typical consultancy services to you provide?

Our project portfolio spans from small, standalone projects to longer projects spanning multiple elements of the development cycle of devices. Services range from very early markets insights, technology assessments, landscaping, early concept generation sprints, to prototyping, Usability Engineering incl. HF studies, Development under full Design Controls up to and including Pilot Manufacturing in-house for e.g. Clinical Trials and Design Transfers to CMO’s

Which types of drug delivery devices do you have experience on?

We have experience on working accross most drug delivery routes of administration, majority within parenteral administration for home uses. Most projects we get involved in often involve complex formulations such as high viscosity, high volume, sensitive API’s. Over the last years, we have seen significant growth in projects within new modalities and targeted delivery, such as intraocular delivery, direct delivery to the brain and nose-to-brain delivery.